Pharmaniaga’s growth plans


The group’s focus in the near term would be South-East Asia, says Zulkarnain.

THINGS are looking up for Pharmaniaga Bhd, at least for the next five to 10 years. The homegrown pharmaceutical company has ambitious plans not only to strengthen its foothold in existing markets but also to foray into new international markets.

For the last two decades, the group had established a strong market presence in Indonesia for drug manufacturing and logistics and distribution (L&D). Now, Pharmaniaga has set its sights on markets like the Middle East, Africa and the United States.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Raising the standards
Bigger index, selective impact
IHH expands in India amid margin pressure
Real test begins after asset sale
Ringgit expected to trade in narrow range against US dollar next week
Sime Darby Property launches nationwide university hackathon
Common property: Who owns what?
Tightening fire safety in residential properties
Building for tomorrow
Malaysia Airlines staff named best in Asia, cabin crew at global 3rd place

Others Also Read